Hepatopulmonary syndrome (HPS) is a frequent pulmonary complication of end-stage liver
disease, characterized by impaired arterial oxygenation induced by intrapulmonary vascular …

Hepatopulmonary syndrome : Current Opinion in Gastroenterology Hepatopulmonary syndrome :
Current Opinion in Gastroenterology Log in or Register Subscribe to journalSubscribe Get new …

Severe chronic liver disease (CLD) may result from portal hypertension, hepatocellular
failure or the combination of both. Some of these patients may develop pulmonary …

Liver cirrhosis poses a global health challenge marked by significant prevalence and
mortality. Current therapeutic options are limited by high costs and immune-mediated …

The major drawback of the current common bile duct ligation (CBDL)-induced
hepatopulmonary syndrome (HPS) animal model is the extremely high mortality rate that …

Background and aims One central factor in hepatopulmonary syndrome (HPS) pathogenesis
is intravascular accumulation of activated macrophages in small pulmonary arteries …

Background/aim Increasing evidence show microRNAs (miRNAs) are associated with
hepatopulmonary syndrome (HPS). The aim of this study was to investigate the role of miR …

Aim: Acute administration of methylene blue (MB) can reverse hypoxemia in patients with
hepatopulmonary syndrome (HPS). We evaluated the effect of chronic MB administration in …

Objective (s): Hepatopulmonary syndrome is a serious respiratory injury caused by chronic
liver disease. Excessive pulmonary capillary angiogenesis is the key pathological event …

Background Hepatopulmonary syndrome (HPS) is a relatively common complication in
patients with decompensated cirrhosis. Our aim was to evaluate the prevalence of HPS, its …